Cooper Companies, Allergan, B&L Provide Investors With Clear Vision In 1999
This article was originally published in The Gray Sheet
Executive Summary
The ability of the Cooper Companies to build market share in the high-margin toric contact lens sector of the specialty lens market while successfully transforming itself from a health conglomerate into a more focused ophthalmic concern helped focus investors attention and lift the firm's stock price significantly in 1999.
You may also be interested in...
Summit's Integrated Wavefront Technology To Break In 2001
Summit Technology, backed by encouraging results from 20 patients treated thus far in an ongoing feasibility trial, is hoping to market a customized refractive laser surgical system integrating the company's CustomCornea wavefront measuring device with its LADARVision system by the end of 2001.
Summit's Integrated Wavefront Technology To Break In 2001
Summit Technology, backed by encouraging results from 20 patients treated thus far in an ongoing feasibility trial, is hoping to market a customized refractive laser surgical system integrating the company's CustomCornea wavefront measuring device with its LADARVision system by the end of 2001.
J&J Professional Division Is Device Industry's Unsung Hero In 1999
Johnson & Johnson's commitment to expanding its medical device business, combined with success in executing and managing drug and device acquisitions, made the company one of the few bright lights among large-cap medical device industry issues in 1999.